Quadrant Capital Group LLC Red Hill Biopharma Ltd. Transaction History

Quadrant Capital Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.55 - $10.36 $8,836 - $20,119	-1,942 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$5.98 - $7.51 $11,164 - $14,021	1,867 Added 2489.33%	1,942 $13,000
Q1 2021 May 12, 2021	SELL	$6.98 - $11.29 $893 - $1,445	-128 Reduced 63.05%	75 $1,000
Q4 2020 Feb 16, 2021	BUY	$7.81 - $10.39 $835 - $1,111	107 Added 111.46%	203 $2,000
Q3 2020 Nov 13, 2020	BUY	$6.34 - $10.83 $608 - $1,039	96 New	96 $1,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.